London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
You will only have one login account. Registering with multiple accounts is not allowed. Any user found to have more than one account on this site will have all, and any future accounts suspended permanently.
Your email and password must only be used by you. If a post is made under your account, it will be considered that it was posted by yourself.
Your account nickname must not be the same, or contain, listed company names or board members' names.
While debating and discussion is fine, we will not tolerate; rudeness, swearing, insulting posts, personal attacks, or posts which are invasive of another's privacy.
You will not;
discuss illegal or criminal activities.
post any confidential or price sensitive information or that is not public knowledge.
post misleading or false statements regarding the share price and performance. Such posts are deemed as market abuse, and may be reported to the appropriate authorities.
post any private communication, or part thereof, from any other person, including from a member of the board of directors of a listed company. Such posts cannot be verified as true and could be deemed to be misleading.
post any personal details (e.g. email address or phone number).
post live price or level 2 updates.
publish content that is not your original work, or infringes the copyright or other rights of any third party.
post non-constructive, meaningless, one word (or short) non-sense posts.
post links to, or otherwise publish any content containing any form of advertising, promotion for goods and services, spam, or other unsolicited communication.
post any affiliate or referral links, or post anything asking for a referral.
post or otherwise publish any content unrelated to the board or the board's topic.
re-post premium share chat posts on regular share chat.
restrict or inhibit any other user from using the boards.
impersonate any person or entity, including any of our employees or representatives.
post or transmit any content that contains software viruses, files or code designed to interrupt, destroy or limit the functionality of this website or any computer software or equipment.
If you are going to post non-English, please also post an English translation of your post.
If you are going to post non-English, please also post an English translation of your post.
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium and Verified Members
Premium Members are members that have a premium subscription with London South East and have access to Premium Chat. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
@sam, ha not at all, I've been more than open with my trading pattern here. If I was de-ramping I'd not be telling you all I bought :) I'm a LTH, opportunity to buy in whilst the price is going lower than we all thought.
@tea, there is NO chance in my opinion that they won't be able to sell product once they have approvals. They have £1m sales lined up and I suspect more will come rapidly with approvals.
Agree, individual posters don't move the share price the MM's do based on volume and volume of buys and sells, we';ve had low volume and this tends to force a share down. But I do believe that bad sentiment plays into the hands of the MMs who want to create a demand for the shares, they make their cut on trades, so which direction a share travels can be understood if there is a wider frustration in sentiment. I think the MM have played a game based on news flow. Nobody's fault I might add, just what happens.
"I was thinking we would be PERFECT for care homes. A portable POC testing would be ideal. I mentioned it here a coupe of times and DB needs to emphasis where his product would be vital for buyers and it may get fast tracked. "
But thats not what they have. They have a lab test, yes a good lab test but its still a lab test. The POC is on the radar for later in the year.
@ticknick -- if GDR are not capable of generating strong sales with the golden product then it doesn't matter what else happens the shareprice will sink. However seems you answer is going to be but it's a good buying opportunity... Also to note if you really believe that this bb has any real impact on the share price you are deluded. Most people just tend to buy on the numbers that they see. If it goes up oh must buy for fear of missing out, if down then quick must sell so not to lose more. That is how most people trade these stocks on Aim. The simple fact is, EU certification since May 22nd and ZERO sales from that date. Not good at all, the EU is probably the easiest market out of the ones being targeted...
good for you Sam, I'm holding off buying more and will review on a daily basis depending on where the price is. Will it drop more, fk knows, so I'm carefully deciding each day now until news comes in. I suspect we are 1-2 weeks away, when it does then sales will follow and the price will rise....
@tea, I'm liking the share price, we've had weeks of people talking the share price down and you know what, now they got what they were harping on about which is great because it can only go so far before news is in and the fall will be reversed. After weeks of hearing people bank pin about no news, falling back to the placing price, moan, moan, moan, they can't moan now its where they said it would be. A buying opportunity and I'm now glad I sold some at £1.55 and I can now buy and wait...
"@Technick -- I'll tell you what is not to like, the share price. While they may have a good product with the very late application for FDA and india markets, coupled to that a early successful EU certificate and zero eu sales there are serious concerns about just what they are doing from a sales and distribution point of view. Have to question if the management team have the people in place to get the product out to market. Even with the pre sales agreements waiting for FDA approval it is still a very small amount of sales. Sorry but the performance of GDR has not been overly positive from a shareholder point of view since May."
That is a spot on rant.
especially concerning for me is:
" coupled to that a early successful EU certificate and zero eu sales there are serious concerns about just what they are doing from a sales and distribution point of view. "
This could easily return to 9p if they don't pull their finger out.
@Technick -- I'll tell you what is not to like, the share price. While they may have a good product with the very late application for FDA and india markets, coupled to that a early successful EU certificate and zero eu sales there are serious concerns about just what they are doing from a sales and distribution point of view. Have to question if the management team have the people in place to get the product out to market. Even with the pre sales agreements waiting for FDA approval it is still a very small amount of sales. Sorry but the performance of GDR has not been overly positive from a shareholder point of view since May.
@Safy, I would argue you are as much letting emotions get to you now. Fundamentals stronger now than before and share price even better to buy than before. Sales will come and market cap will grow proportionately. It's all about sales short term, POC updates medium term, POC sales and new test development long term. What's not to like!
Thats why i was alarmed at why we recruited someone on a temp contract only recently, im disappointed mate, its against my own judgement that i kept this share. The problem for me was that having been involved since prior to 300p, i let emotion get the better of me. Otherwise all the warning signs were there.
EE, Safy, it comes down to sample. If saliva can be used instead of nasopharyngeal swabs we are on to a winner, otherwise it will require some careful sample taking which will limit its applicability in my view. Those swabs are tricky (and unpleasant) and are what is leading to false negatives as samples have not been taken correctly from what I read in the literature. Saliva removes those issues and anyone can take a saliva sample. Hopefully GDR will tell us how that is looking after their approvals and sales RNSs....
Safy, I was thinking we would be PERFECT for care homes. A portable POC testing would be ideal. I mentioned it here a coupe of times and DB needs to emphasis where his product would be vital for buyers and it may get fast tracked. I agree about approvals. That's why i find it shocking application was not made late may. He now has a dependency holding him back and he can't do f all but wait.
ODX, a massive buy just now which i'm sure you've seen. I got 14k worth of shares there and i think a poc, quality antibody will be in demand for a while to come so no stress there. Placing shares may affect us in the short term tho.